Merck & Co. , Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck & Co. with three other
companies in this sector in the United States:
sales of $39.30 billion
of which 57%
of which 66%
was Innovative Medicines), and
of which 83%
Merck & Co. reported sales of $40.12 billion
December of 2017.
a very small
increase of 0.8%
versus 2016, when the company's sales were $39.81 billion.
Sales of All Other saw an increase
that was more than double the company's growth rate: sales were up
10.6% in 2017, from
$3.86 billion to $4.27 billion.
Not all segments of Merck & Co. experienced an increase in sales in 2017:
sales of Unallocated fell 42.1% to $460.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).